ReShape Lifesciences, Inc. revenue for the last year amounted to 8.68 M USD, the most of which — 8.68 M USD — came from its highest performing source at the moment, Minimally Invasive Medical Devices, the year earlier bringing 11.24 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ReShape Lifesciences, Inc. 7.13 M USD, and the year before that — 9.23 M USD.